Testosterone Reduces Tight Junction Complexity and Down-Regulates Expression of Claudin-4 and Occludin in the Endometrium in Ovariectomized, Sex-Steroid Replacement Rats

    December 2019 in “ in Vivo
    Mohd Noriznan Mokhtar, Nelli Giribabu, Naguib Salleh
    Image of study
    TLDR Testosterone makes the connections in the uterus lining simpler and lowers certain protein levels, which might lead to infertility.
    The study, conducted on 6 ovariectomized Sprague-Dawley rats per treatment group, demonstrated that testosterone reduced the complexity of tight junctions and decreased the expression of claudin-4 and occludin in the endometrium during uterine receptivity. The administration of flutamide or finasteride did not reverse these effects, indicating that testosterone's impact on tight junction morphology and protein expression is not mediated by the genomic pathway or by its active metabolite, dihydrotestosterone (DHT). These findings suggest that high levels of testosterone may disrupt uterine fluid regulation and impair embryo attachment and implantation, potentially leading to infertility. The study raises the possibility that testosterone's effects on the uterus might be through a non-genomic pathway, which had not been previously reported.
    Discuss this study in the Community →

    Research cited in this study

    1 / 1 results

    Related Community Posts Join

    6 / 1000+ results
      Can I still save my hairline at age of 15?

      community Can I still save my hairline at age of 15?

      in General  413 upvotes 5 days ago
      A 15-year-old is concerned about hair loss, possibly at Norwood 2 or 3, and is using shampoos and conditioners recommended by a trichologist. Suggestions include considering topical minoxidil and consulting a doctor about topical anti-DHT treatments like finasteride or RU58841, but avoiding 5-alpha-reductase inhibitors at this age.

      community What ever happened to pyrilutamide?

      in Technology  49 upvotes 2 years ago
      Pyrilutamide, a potentially effective hair loss treatment; other topical treatments like RU58841 and CB-03-01 that may have fewer side effects than Pyrilutamide; and the Phase 3 clinical trials of Pyrilutamide, which is likely to be approved by the FDA soon.

    Related Research

    1 / 1 results